APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This study will compare the anti-tumor efficacy of apricoxib and gemcitabine/erlotinib with
placebo and gemcitabine/erlotinib in patients with advanced pancreatic cancer.